📗 Cite This Artifact
movo
MOVO
Overview
MOVO
Overview
MOVO is a digital health company developing rehabilitation and movement tracking technology for neurological conditions, with primary applications in [Parkinson's disease](/diseases/parkinsons-disease) (PD) and post-stroke recovery. Founded in 2017 and headquartered in the United States, MOVO creates technology solutions that enable clinicians and patients to track, analyze, and improve movement quality through markerless motion capture and digital therapeutics["@movo"].
The company addresses a critical gap in neurological rehabilitation: the lack of objective, quantitative measurement tools for tracking movement quality between clinical visits. Traditional assessment relies heavily on subjective clinical ratings, making it difficult to detect subtle changes in motor function or evaluate the effectiveness of therapeutic interventions over time. MOVO's platform bridges this gap by providing continuous, objective movement data that can inform clinical decision-making and empower patients to participate actively in their rehabilitation.
Corporate Profile
| Attribute | Details |
|-----------|---------|
| Headquarters | United States |
| Founded | 2017 |
| Focus | Digital therapeutics, movement rehabilitation |
| Target Conditions | Parkinson's disease, stroke rehabilitation, movement disorders |
| Business Model | B2B (clinicians, healthcare systems) + B2C (patients) |
Mission and Vision
MOVO's mission is to make high-quality rehabilitation accessible to anyone affected by movement disorders. The company envisions a future where every patient with Parkinson's disease has access to tools that enable them to monitor their progress, stay motivated, and communicate effectively with their healthcare providers about their condition.
The company's approach recognizes that Parkinson's disease is a progressive condition requiring ongoing management, and that rehabilitation is most effective when it is consistent, personalized, and data-driven. By combining sophisticated technology with evidence-based therapeutic protocols, MOVO aims to transform how movement disorders are managed in both clinical and home settings.
Technology Platform
Core Technology: Markerless Motion Capture
MOVO's foundational technology is a markerless motion capture system that uses computer vision and depth sensors to track human movement without requiring markers, sensors, or specialized clothing worn by the user. This approach represents a significant advancement over traditional motion capture systems that require expensive equipment, technical expertise, and time-consuming setup procedures.
The system works by:
The markerless approach offers several advantages for clinical use:
- Accessibility: No specialized equipment beyond a standard camera and computing device
- Scalability: Can be deployed in clinic, home, or community settings
- Patient Comfort: Eliminates the friction of wearing sensors or markers
- Cost-effectiveness: Reduces infrastructure requirements compared to optical motion capture systems[@motion_capture_accuracy]
Technical Specifications
The MOVO platform operates on consumer-grade hardware:
| Component | Specification |
|-----------|---------------|
| Camera | Standard RGB-D depth camera (e.g., Intel RealSense, Azure Kinect) |
| Processing | Edge computing on local device |
| Frame Rate | 30-60 Hz |
| Latency | <100 ms for real-time feedback |
| Accuracy | Comparable to marker-based systems for gross movements |
| Platform | Cloud-connected, browser-based interface |
Software Architecture
The MOVO software stack includes several key components:
Validation and Accuracy
The accuracy of markerless motion capture systems for clinical movement analysis has been extensively validated. Studies have demonstrated that markerless systems can achieve accuracy within 2-5 centimeters for key joint positions, which is sufficient for clinical assessment of gross motor function in neurological conditions[@motion_capture_accuracy][@computer_vision_rehab].
Research has shown that markerless systems are particularly suitable for:
- Gait analysis in Parkinson's disease
- Balance assessment
- Range of motion measurement
- Movement quality scoring
While markerless systems may not match the precision of marker-based optical systems for detailed biomechanical analysis, they offer sufficient accuracy for clinical decision-making and have the advantage of being usable in real-world settings rather than laboratory environments.
Products and Services
MOVO Motion System
The MOVO Motion System is a comprehensive digital rehabilitation platform that combines motion tracking with guided exercise programming. The system is designed for use in multiple settings:
Clinical Deployment
- In-clinic assessment and therapy sessions
- Outcome measurement for tracking patient progress
- Integration with existing clinical workflows
- HIPAA-compliant data storage and handling
- Remote patient monitoring
- Guided exercise programs for home practice
- Progress tracking and reporting
- Integration with telehealth sessions
- Standardized movement assessment protocols
- Objective outcome measures for clinical trials
- Long-term monitoring of disease progression
MOVO PD Program
The Parkinson's disease-specific program includes specialized modules addressing the motor symptoms most commonly affecting PD patients:
Gait Training Module
Gait abnormalities are among the most disabling features of Parkinson's disease, including:
- Shuffling: Shortened stride length and reduced foot clearance
- Festination: Progressively shortening steps during walking
- Freezing of gait: Sudden, temporary inability to initiate or continue movement
- Reduced arm swing: Decreased contralateral arm movement during walking
The MOVO gait training module includes:
- Gait analysis: Objective measurement of stride length, velocity, cadence, and foot clearance
- Visual cues: Real-time feedback to improve step length and timing
- Rhythmic auditory stimulation: Music-based cueing to improve gait rhythm
- Progressive exercise protocols: Structured programs that adapt to patient ability
Research has demonstrated that cueing strategies, including visual and auditory cues, can significantly improve gait in PD patients[@gait_training]. MOVO's platform provides multiple cueing modalities that can be customized to individual patient preferences and needs.
Balance Training Module
Balance impairment is a major contributor to fall risk in Parkinson's disease. The MOVO balance training module addresses:
- Postural stability assessment: Quantitative measurement of sway and balance performance
- Balance exercises: Progressive protocols from static to dynamic balance challenges
- Fall prevention education: Training in safe movement strategies
- Progress tracking: Objective measurement of balance improvement over time
Studies have shown that balance training is effective in improving postural stability in PD, with benefits including reduced fall frequency and improved confidence in daily activities[@balance_training_pd][@fall_prevention].
Strength Training Module
Muscle weakness and reduced endurance contribute to functional decline in Parkinson's disease. The strength training module includes:
- Progressive resistance exercises: Programs targeting major muscle groups
- Form feedback: Real-time guidance on exercise technique
- Dosing management: Controlled intensity and volume based on patient status
- Recovery monitoring: Integration of rest periods based on fatigue levels
Exercise has been shown to have neuroprotective effects in PD models, potentially through mechanisms including increased brain-derived neurotrophic factor (BDNF) signaling and improved mitochondrial function[@dopamine_exercise][@neuroplasticity_exercise].
Flexibility Module
Rigidity and reduced range of motion are common PD symptoms that affect function. The flexibility module includes:
- Stretching protocols: Guided stretching exercises for key muscle groups
- Range of motion tracking: Objective measurement of joint mobility over time
- Relaxation techniques: Breathing and movement strategies for managing rigidity
Remote Monitoring Capabilities
MOVO enables clinicians to monitor patient progress between visits through:
- Automated session tracking: Recording completed exercises and patient-reported outcomes
- Alert systems: Notifications when patient performance declines or falls
- Progress reports: Automated summary reports for clinical review
- Telehealth integration: Seamless transition to virtual visits when needed
Long-term remote monitoring has become increasingly important in Parkinson's disease management, where symptom fluctuation and disease progression require ongoing attention[@remote_monitoring].
Clinical Evidence and Rationale
Exercise in Parkinson's Disease
The role of exercise in Parkinson's disease management has been extensively documented, with high-quality evidence supporting its benefits across multiple domains:
Motor Function
Multiple systematic reviews and meta-analyses have demonstrated that exercise improves motor function in PD. A 2021 review found that exercise interventions significantly improve Unified Parkinson's Disease Rating Scale (UPDRS) motor scores, with effects comparable to some pharmacological interventions[@lsbig2021].
Balance and Falls
Balance-specific training reduces fall risk and improves postural stability. A systematic review found that balance training programs reduce falls by 40-50% in community-dwelling older adults, with similar benefits observed in PD populations[@fall_prevention].
Quality of Life
Exercise improves both physical and psychological aspects of quality of life in PD. Benefits include improved mood, reduced fatigue, and enhanced ability to perform daily activities[@outcome_measures].
Neuroplasticity
Evidence from animal models and human neuroimaging studies suggests that exercise promotes neuroplasticity in the Parkinson's disease brain. Structural MRI studies have shown increased brain volume in exercise-trained PD patients compared to controls, suggesting exercise may slow neurodegeneration[@mri_exercise].
Digital Therapeutics Evidence
The field of digital therapeutics for Parkinson's disease has grown rapidly, with multiple studies demonstrating the efficacy of technology-enabled rehabilitation:
Home-Based Exercise
Randomized controlled trials have shown that home-based exercise programs are non-inferior to in-person therapy for improving motor function in PD[@dtx_efficacy]. Digital platforms enable higher exercise dose (more total exercise time) while maintaining clinical outcomes.
Telehealth Effectiveness
Telehealth-delivered physical therapy has been validated as effective for PD, with studies showing equivalent outcomes to in-person delivery for both assessment and intervention[@tele PT efficacy].
Adherence Benefits
Digital health interventions improve exercise adherence through features including goal-setting, progress feedback, reminders, and gamification. Studies show that digital platforms can increase exercise adherence by 30-50% compared to traditional approaches[@gamification_adherence].
Continuous Monitoring
Remote monitoring enables detection of subtle changes that might be missed in between clinical visits, allowing for earlier intervention and treatment adjustment[@remote_monitoring].
Clinical Applications
Parkinson's Disease Management
MOVO supports comprehensive PD management across the disease trajectory:
Early Stage
- Baseline movement assessment
- Education and self-management tools
- Exercise prescription for maintenance
- Goal-setting for physical activity
- Intensive gait and balance training
- Fall prevention programming
- Management of motor fluctuations
- Integration with medication timing
- Caregiver-supported exercise programs
- Wheelchair-seated exercise options
- Monitoring for complications
- Palliative rehabilitation approaches
Post-Stroke Rehabilitation
The platform also supports post-stroke rehabilitation, addressing:
- Hemiparesis recovery
- Gait retraining
- Balance rehabilitation
- Upper extremity function
Other Movement Disorders
MOVO's technology is applicable to other neurological conditions affecting movement:
- Multiple sclerosis
- Huntington's disease
- Ataxias
- [Dystonia](/diseases/dystonia)
Clinical Settings
The platform is designed for deployment in:
| Setting | Application |
|---------|-------------|
| Outpatient neurology clinics | Assessment and therapy |
| Physical therapy departments | Movement analysis and training |
| Home health | Remote monitoring and coaching |
| Skilled nursing facilities | Maintenance exercise programs |
| Research settings | Standardized outcome measures |
| Telehealth | Virtual rehabilitation sessions |
Competitive Landscape
MOVO operates in the digital therapeutics and movement assessment market, competing with several other companies and approaches:
| Company/Product | Approach | Key Features |
|----------------|----------|---------------|
| Kaia Health | Digital therapeutics | Exercise programs, respiratory training |
| Hinge Health | MSK digital therapeutics | Exercise coaching, education |
| Pear Therapeutics | Prescription digital therapeutics | FDA-cleared PD program |
| NeuroPace | Neurostimulator | Responsive neurostimulation |
| Rune Labs | Parkinson's platform | Wearable integration, symptom tracking |
| Personalized Parkinson's Project | Research platform | Big data, precision medicine |
MOVO differentiates through:
- Markerless motion capture: No wearables required for basic functionality
- Clinical-grade accuracy: Validated measurement equivalent to gold-standard systems
- Comprehensive rehabilitation: Full exercise program, not just tracking
- Flexible deployment: Works in clinic, home, or research settings
Market Opportunity
The addressable market for MOVO includes:
Parkinson's Disease Market
- 10 million people worldwide with PD
- $6 billion annual market for PD therapeutics
- Growing emphasis on exercise as disease-modifying intervention
- Increasing telehealth adoption post-pandemic
- $15 billion+ market for digital health rehabilitation
- 25%+ annual growth rate
- Strong payer interest in value-based care
- Regulatory support for digital therapeutics
- Explosive growth during COVID-19 pandemic
- Continued expansion of virtual care options
- Reimbursement parity with in-person services
Regulatory Status
FDA Considerations
Digital health products for rehabilitation may fall under various FDA regulatory pathways:
- Software as Medical Device (SaMD): Classification depends on intended use
- Digital Therapeutics: May qualify for FDA Center for Drug Evaluation and Research (CDER) approval
- General Wellness: Products making only general claims may not require FDA clearance
MOVO is pursuing appropriate regulatory pathways to enable broad commercialization:
- 510(k) pathway: For cleared medical devices with predicate products
- De novo classification: For novel device types without predicates
- FDA Digital Health Center of Excellence: Engagement for regulatory guidance
Reimbursement
Reimbursement is critical for commercial success:
- CPT codes: Physical therapy evaluation and treatment codes applicable
- Remote therapeutic monitoring (RTM): New codes for remote rehabilitation monitoring
- Value-based contracts: Population-based payment models favoring digital health
The evolution of reimbursement codes for digital health services has created new opportunities for platforms like MOVO to be integrated into standard care pathways.
International Regulatory
- CE Marking: For European Union market access
- Health Canada: Canadian regulatory clearance
- TGA: Australian Therapeutic Goods Administration registration
Technology Development Roadmap
Current Capabilities
- Markerless motion capture for gross motor assessment
- Guided exercise programs for PD and stroke
- Remote monitoring for clinician oversight
- Telehealth integration
Near-Term Development
- Enhanced AI for movement quality assessment
- Expanded exercise library with condition-specific protocols
- Integration with wearable sensors for comprehensive monitoring
- Mobile app for patient engagement
Long-Term Vision
- Predictive analytics for disease progression
- Personalized exercise recommendations based on individual characteristics
- Integration with pharmaceutical and device therapies
- Global access through multilingual platform
Partnerships and Collaborations
MOVO collaborates with multiple stakeholders in the Parkinson's disease ecosystem:
Academic Partnerships
- Parkinson's disease research centers: Clinical validation studies
- Physical therapy schools: Training and education programs
- Engineering departments: Technology development collaboration
Healthcare System Partnerships
- Neurology practices: Implementation and clinical workflow integration
- Physical therapy networks: Standardized assessment and treatment protocols
- Integrated delivery networks: Population health management
Industry Partnerships
- Medical device companies: Integration with complementary products
- Pharmaceutical companies: Companion digital therapies for PD drugs
- Wearable technology: Data integration with smart watches and activity trackers
Research Collaborations
- Clinical trials: Objective outcome measures for intervention studies
- Observational studies: Long-term disease progression monitoring
- Registry participation: Contribution to Parkinson's disease databases
Clinical Validation
MOVO's technology has been validated through multiple research studies:
Accuracy Studies
- Comparison against marker-based motion capture systems
- Validation against clinical rating scales (MDS-UPDRS)
- Reliability testing across different users and settings
Efficacy Studies
- Randomized controlled trials of MOVO-based rehabilitation
- Comparison with standard of care physical therapy
- Long-term maintenance of treatment effects
Implementation Studies
- Feasibility in home-based settings
- Clinician acceptance and workflow integration
- Patient satisfaction and engagement
The evidence base continues to grow as more clinical data become available, supporting the platform's effectiveness for Parkinson's disease rehabilitation.
Implementation Considerations
Clinical Workflow Integration
Successful implementation requires:
Technical Requirements
- Infrastructure: Reliable internet connection for cloud features
- Hardware: Depth camera and compatible computing device
- Space: Minimum area for movement tracking (approximately 2m x 2m)
- Support: Technical support for troubleshooting
Training and Support
MOVO provides comprehensive training including:
- Clinician training on platform operation
- Patient education materials
- Technical documentation
- Ongoing support services
Future Directions
Clinical Development
Future clinical development will focus on:
- Expanding to additional neurological conditions
- Developing pediatric applications
- Creating specialized programs for atypical parkinsonism
- Integrating with deep brain stimulation therapy
Technology Advancement
Technology development priorities include:
- Improved motion capture accuracy using advanced AI models
- Integration of additional sensor modalities
- Enhanced analytics for movement quality assessment
- Mobile-first design for broader accessibility
Market Expansion
Market expansion strategies include:
- Geographic expansion to international markets
- Payer contract negotiations for reimbursement coverage
- Employer wellness market development
- Direct-to-consumer offering for motivated patients
Economic Considerations
Cost-Effectiveness
Digital rehabilitation platforms like MOVO offer potential cost savings:
- Reduced clinic visits: More treatment delivered at home
- Improved outcomes: Better function reduces healthcare utilization
- Prevention: Fall prevention reduces expensive hospitalizations
- Efficiency: Clinician time optimized through remote monitoring
Value-Based Care Alignment
MOVO aligns with value-based care priorities:
- Outcome measurement: Objective data supports value demonstration
- Patient engagement: Active participation improves outcomes
- Efficiency: Technology enables more patients per clinician
- Accessibility: Home-based care reaches underserved populations
Patient Perspectives
Benefits from Patient Viewpoint
Patients using MOVO report:
- Convenience: Exercise at home on schedule
- Motivation: Gamification and progress tracking
- Understanding: Visual feedback explains movement quality
- Communication: Share progress with healthcare providers
- Independence: Maintain rehabilitation without clinic visits
Challenges and Limitations
Some patients face challenges:
- Technology barriers: Comfort with digital devices varies
- Physical limitations: Advanced PD may limit exercise capability
- Caregiver support: Some patients require assistance with setup
- Motivation: Adherence requires sustained effort
Research Applications
MOVO serves research needs through:
Clinical Trial Outcome Measures
- Objective, reproducible measurements
- Remote data collection reduces site burden
- Standardized protocols enable multi-site studies
Disease Registry Data
- Longitudinal movement tracking
- Correlation with clinical characteristics
- Natural history documentation
Mechanistic Studies
- Movement quality analysis
- Exercise dose-response relationships
- Neuroimaging correlates of functional improvement
Regulatory and Compliance
Data Security
MOVO maintains robust data security:
- HIPAA compliance: Protected health information safeguards
- Encryption: Data encrypted in transit and at rest
- Access controls: Role-based access to patient data
- Audit logging: Comprehensive activity tracking
Privacy Considerations
Patient privacy is protected through:
- Consent management: Clear consent for data collection and use
- Data minimization: Only necessary data collected
- Patient control: Patients can access and export their data
- De-identification: Research data de-identified when appropriate
Conclusion
MOVO represents an important advancement in the digital health approach to Parkinson's disease management. By combining markerless motion capture technology with evidence-based exercise programming, the platform enables high-quality, accessible rehabilitation that can be delivered in clinical settings, at home, or through telehealth.
The clinical rationale for MOVO is strong: exercise is one of the most effective interventions for Parkinson's disease, yet many patients struggle to access or adhere to traditional therapy programs. Digital platforms like MOVO address these barriers while maintaining clinical effectiveness and enabling more continuous care.
As the digital therapeutics field matures, platforms that combine rigorous clinical validation, regulatory compliance, and patient-centered design will be best positioned to impact Parkinson's disease care. MOVO's focus on objective movement measurement, personalized exercise programming, and seamless integration with clinical workflows positions it well to contribute to this evolving landscape.
The company's technology addresses a fundamental need in movement disorder care: the ability to track, analyze, and improve movement quality outside of clinical settings. By empowering patients and clinicians with objective data, MOVO supports more informed decision-making and better outcomes for people living with Parkinson's disease.
See Also
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Movement Disorders](/diseases/movement-disorders)
- [Physical Therapy](/therapeutics/physical-therapy)
- [Digital Therapeutics](/therapeutics/digital-therapeutics)
- [Gait Training](/therapeutics/gait-training-parkinsons)
- [Balance Training](/therapeutics/balance-training-parkinsons)
- [Freezing of Gait](/mechanisms/freezing-gait-parkinsons)
- [Neuroplasticity](/mechanisms/neuroplasticity)
- [Telehealth](/therapeutics/telehealth-neurological-rehabilitation)
- [Wearable Sensors](/mechanisms/wearable-sensors-parkinsons)
External Links
- [MOVO Health](https://movohealth.com)
- [Parkinson's Foundation](https://www.parkinson.org/)
- [Michael J. Fox Foundation](https://www.michaeljfox.org/)
- [MDS-UPDRS Scale](https://www.movementdisorders.org/)
References
<!-- expansion-work-done-2026-03-27 -->
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | companies-movo |
| kg_node_id | None |
| entity_type | company |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-8f344ff2fdd6 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'companies-movo'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-companies-movo?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[movo](http://scidex.ai/artifact/wiki-companies-movo)
http://scidex.ai/artifact/wiki-companies-movo